Showing results (461-470 of 1,019) with videos related to

Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|August 13, 2024
Healthcare Resource Use and Costs Among Individuals with Vitiligo and Psychosocial Comorbidities: Retrospective Analysis of an Insured US PopulationJennifer H Lofland, Samyuktha Darbha, Ahmad B Naim, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 10, 2024
Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test from a US Societal PerspectiveVladislav Berdunov, Gebra Cuyun Carter, Ewan Laws, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 11, 2024
Cost-Effectiveness and Budget Impact Analyses of Selective Internal Radiation Therapy versus Atezolizumab Plus Bevacizumab from a German Statutory Health Insurance PerspectiveBjoern Schwander, Katharina Klesper, Siegbert Rossol, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 4, 2024
Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature ReviewCharles D Burger, Yuen Tsang, Marie Chivers, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 30, 2024
Timeliness of Health Technology Assessments and Price Negotiations for Oncology Drugs in CanadaNigel S B Rawson, David J Stewart
Clinicoeconomics and Outcomes Research : CEOR|December 10, 2025
Are Nutritional Interventions Worthwhile in Cancer Patients? A Systematic Review on Economic EvaluationHieu Thi Thanh Nguyen, Arthorn Riewpaiboon, Hien Thi Bich Tran, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 25, 2024
Budget Impact Analysis of Implementing Patient Blood Management in the Cardiovascular Surgery Department of a Turkish Private HospitalMehtap Tatar, Cansu Selcan Akdeniz, Utku Zeybey, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 10, 2025
Financial Cost of Treating Polytrauma in a Public Tertiary Hospital in the South-Eastern Democratic Republic of Congo: A Case Series StudyChadrack Kabeya Diyoka, Laetitia Ngongo Mwanvua, Marcellin Shauri Kalemera, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 31, 2024
The Cost-Effectiveness of Dolutegravir in Combination with Tenofovir and Lamivudine for HIV Therapy: A Systematic ReviewSanti Aprilianti, Auliasari M Utami, Auliya A Suwantika, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 18, 2024
Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14)Jorge Echeverri, Rui Martins, Kai Harenski, et al.
Pageof 102